| Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis (NCT02369926) | Transparency Life Sciences | 2014-11-01 |
| Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults (NCT02307851) | Novavax | 2014-11-01 |
| A Clinical Study of Treating Influenza With Liugan Shuangjie Heji (NCT02572583) | Dongfang Hospital Beijing University of Chinese Medicine | 2014-11-01 |
| Effects of Nicotine-Free Hookah Smoking on Blood Flow to the Heart, Muscle and Skin (NCT02310373) | Cedars-Sinai Medical Center | 2014-11-01 |
| Whole Breast RT on Prone Position in Korean Women (NCT02231112) | Samsung Medical Center | 2014-11-01 |
| The Clinical Therapeutic Effects and Safety of Tissue-engineered Bone (NCT02748343) | Xijing Hospital | 2014-11-01 |
| Vemurafenib and TIL Therapy for Metastatic Melanoma (NCT02354690) | Inge Marie Svane | 2014-11-01 |
| Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children (NCT02165813) | Telethon Kids Institute | 2014-11-01 |
| 1% Metformin Gel in the Treatment of Class II Furcation Defects (NCT02580331) | Government Dental College and Research Institute, Bangalore | 2014-11-01 |
| Pre-Hospital Use of Plasma for Traumatic Hemorrhage (NCT02303964) | Virginia Commonwealth University | 2014-11-01 |
| Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma (NCT02219178) | Cancer Trials Ireland | 2014-11-01 |
| Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (NCT01842503) | Laboratorio Farmaceutico Ct S.r.l. | 2014-11-01 |
| A Study: Pure CBD as Single-agent for Solid Tumor. (NCT02255292) | Hadassah Medical Organization | 2014-11-01 |
| Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years (NCT02247362) | VaxInnate Corporation | 2014-11-01 |
| Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases (NCT02260531) | Dana-Farber Cancer Institute | 2014-11-01 |
| Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial (NCT02565316) | Shiraz University of Medical Sciences | 2014-11-01 |
| Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma (NCT02221492) | Genzyme, a Sanofi Company | 2014-11-01 |
| Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 (NCT02317471) | Chinese PLA General Hospital | 2014-11-01 |
| Peginterferon and TIL Therapy for Metastatic Melanoma (NCT02379195) | Inge Marie Svane | 2014-11-01 |
| Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas (NCT02280785) | Samsung Medical Center | 2014-11-01 |
| 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study (NCT02332005) | NeuromaxBionevia | 2014-11-01 |
| Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma (NCT02272699) | Peking University | 2014-11-01 |
| HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection (NCT02309918) | HepNet Study House, German Liverfoundation | 2014-11-01 |
| Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis (NCT02201524) | Pfizer | 2014-11-01 |
| A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma (NCT02328261) | Betta Pharmaceuticals Co., Ltd. | 2014-11-01 |
| Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients (NCT02275286) | Grupo Espanol de Investigacion en Sarcomas | 2014-11-01 |
| Prediction of NEC With Urinary iFABP (NCT01805206) | Loma Linda University | 2014-11-01 |
| A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer (NCT02293707) | Laboratoires Leurquin Mediolanum | 2014-11-01 |
| Prevena™ Incision Management System vs Conventional Management for Wound Healing (NCT02892435) | Ospedale Misericordia e Dolce | 2014-11-01 |
| Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study (NCT02474966) | University of Roma La Sapienza | 2014-11-01 |
| Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck (NCT02558387) | Samsung Medical Center | 2014-11-01 |
| Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients (NCT02246686) | Bayer | 2014-11-01 |
| OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI (NCT02310802) | ObsEva SA | 2014-11-01 |
| Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT02312544) | Ocular Therapeutix, Inc. | 2014-11-01 |
| A Phase 2 Study With CC-220 in Skin Sarcoidosis (NCT02192489) | Celgene | 2014-11-01 |
| Lonafarnib With and Without Ritonavir in HDV (LOWR-1) (NCT02430181) | Eiger BioPharmaceuticals | 2014-11-01 |
| The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity (NCT02260973) | Physician Recommended Nutriceuticals | 2014-11-01 |
| Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma (NCT02173093) | University of Virginia | 2014-11-01 |
| Comparison Between Biodentine and Calcium Hydroxide in the Indirect Pulp Treatment on Primary Teeth (NCT02799927) | José Arturo Garrocho Rangel | 2014-11-01 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy (NCT02223182) | DBV Technologies | 2014-11-01 |
| Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02227251) | Karyopharm Therapeutics Inc | 2014-11-01 |
| VSV-ZEBOV Geneva Vaccine Trial (NCT02287480) | University Hospital, Geneva | 2014-11-01 |
| Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus (NCT02303405) | Charles Drew University of Medicine and Science | 2014-11-01 |
| Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia (NCT02115672) | Sheba Medical Center | 2014-11-01 |
| Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas (NCT02343224) | Emory University | 2014-11-01 |
| Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib (NCT02158702) | National University Hospital, Singapore | 2014-11-01 |
| Protective Effects of EPI-743 on Noise-Induced Hearing Loss (NCT02257983) | Edison Pharmaceuticals Inc | 2014-10-31 |
| RTA 408 Capsules in Patients With Melanoma - REVEAL (NCT02259231) | Biogen | 2014-10-31 |
| Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer (NCT02178436) | Mohammed Najeeb Al Hallak | 2014-10-31 |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain (NCT02270983) | Forest Laboratories | 2014-10-31 |
| An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder (NCT02226458) | Edison Pharmaceuticals Inc | 2014-10-31 |
| Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis (NCT02260557) | Actelion | 2014-10-31 |
| Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women (NCT02188459) | Henry Kranzler | 2014-10-30 |
| Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations (NCT02272478) | Cardiff University | 2014-10-30 |
| Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation (NCT03577249) | A.O.U. Città della Salute e della Scienza | 2014-10-30 |
| Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome (NCT02213172) | KGK Science Inc. | 2014-10-30 |
| The Effect of the Serratus Block on Pain Control After Breast Surgery (NCT02453516) | Women's College Hospital | 2014-10-29 |
| A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002) (NCT02296476) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-10-29 |
| Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts (NCT04483934) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2014-10-28 |
| A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine (NCT02693652) | Aribio Lab Co., Ltd. | 2014-10-28 |
| Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS) (NCT02103478) | Astex Pharmaceuticals, Inc. | 2014-10-28 |
| A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy (NCT02238483) | AstraZeneca | 2014-10-28 |
| Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS) (NCT02160782) | Mirum Pharmaceuticals, Inc. | 2014-10-28 |
| Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer (NCT02280356) | Memorial Sloan Kettering Cancer Center | 2014-10-28 |
| A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod (NCT02215616) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-10-28 |
| Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT02250937) | M.D. Anderson Cancer Center | 2014-10-27 |
| Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia (NCT02135874) | M.D. Anderson Cancer Center | 2014-10-27 |
| Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) (NCT02255097) | Merck Sharp & Dohme LLC | 2014-10-24 |
| Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer (NCT02213042) | Novartis Pharmaceuticals | 2014-10-24 |
| A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (NCT02193776) | Global Alliance for TB Drug Development | 2014-10-23 |
| Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD. (NCT02264288) | Celularity Incorporated | 2014-10-23 |
| Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide (NCT02282904) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-23 |
| T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer (NCT02133196) | National Cancer Institute (NCI) | 2014-10-23 |
| Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02207530) | AstraZeneca | 2014-10-23 |
| A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC (NCT01395641) | National Taiwan University Hospital | 2014-10-22 |
| A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS (NCT02488408) | BerGenBio ASA | 2014-10-22 |
| Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome (NCT02291029) | Novartis Pharmaceuticals | 2014-10-22 |
| Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation (NCT02231775) | M.D. Anderson Cancer Center | 2014-10-22 |
| A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) (NCT02091206) | Jazz Pharmaceuticals | 2014-10-22 |
| Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2 (NCT02278562) | VA Office of Research and Development | 2014-10-22 |
| To Evaluate the Optimum Dose of Platelet Rich Plasma in Knee Osteoarthritis and Compare Efficacy With Hyaluronic Acid (NCT04198467) | Dr. Himanshu Bansal Foundation | 2014-10-21 |
| Extension Study to Evaluate the Safety and Efficacy of Luspatercept in Participants With β-Thalassemia Previously Enrolled in A536-04 (A536-06/MK-6143-004) (NCT02268409) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2014-10-20 |
| Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant (NCT02232178) | Innocoll | 2014-10-20 |
| JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis (NCT02251821) | Fred Hutchinson Cancer Center | 2014-10-20 |
| Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR (NCT02227368) | AstraZeneca | 2014-10-20 |
| Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer (NCT02151019) | Cancer Trials Ireland | 2014-10-17 |
| Heme Arginate in Cardiac Surgery Patients (NCT02142699) | University of Edinburgh | 2014-10-17 |
| A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis (NCT02237365) | Oxford University Clinical Research Unit, Vietnam | 2014-10-17 |
| Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial (NCT02049307) | Hennepin Healthcare Research Institute | 2014-10-16 |
| Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma (NCT02337946) | Takeda | 2014-10-16 |
| Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT02100423) | Paolo Caimi, MD | 2014-10-16 |
| Bay98-7196, Dose Finding / POC Study (NCT02203331) | Bayer | 2014-10-16 |
| A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria (NCT02332824) | Takeda | 2014-10-16 |
| Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (NCT02002819) | University of Minnesota | 2014-10-16 |
| A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma (NCT02257567) | Hoffmann-La Roche | 2014-10-15 |
| Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? (NCT02232399) | Göteborg University | 2014-10-15 |
| Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC) (NCT02281630) | Kissei Pharmaceutical Co., Ltd. | 2014-10-15 |
| Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma (NCT02006030) | Polaris Group | 2014-10-15 |
| Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome (NCT02243579) | National Cancer Institute (NCI) | 2014-10-15 |
| Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection (NCT02251717) | Gilead Sciences | 2014-10-14 |